Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Carrier-Mediated Transport01:06

Carrier-Mediated Transport

832
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
832
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

99
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
99
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

164
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
164
Prodrugs01:30

Prodrugs

3.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
3.6K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

6.6K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.6K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

978
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
978

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody-Assisted Protection from Paraoxon and Nerve Agent Model Compounds.

Journal of medicinal chemistry·2026
Same author

Genomic Insights Into Risperidone Treatment Outcomes in Children and Adolescents: Experience From a Psychiatric Hospital Serving Rural Youth.

Clinical pharmacology and therapeutics·2026
Same author

Community Partnerships in Clinical Research: A Framework for Sustainability and Resilience.

Clinical pharmacology and therapeutics·2026
Same author

Ibrexafungerp: Mechanism of Action, Clinical, and Translational Science.

Clinical and translational science·2025
Same author

Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges.

Clinical pharmacology and therapeutics·2025
Same author

Perspectives on Using Pharmacogenomics to Guide Tobacco Cessation: Survey Results From an American Indian Community.

Clinical and translational science·2025

Related Experiment Video

Updated: Dec 6, 2025

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria
06:38

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria

Published on: February 28, 2025

576

Food dyes as P-glycoprotein modulators.

Jack W Staples1, Jessica M Stine1, Eero Mäki-Lohiluoma1

  • 1Department of Biomedical and Pharmaceuticals Sciences, University of Montana, Missoula, MT, United States.

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|October 4, 2020
PubMed
Summary

Six common food dyes were tested for interactions with P-glycoprotein (P-gp), a key drug transporter. These food dyes do not activate or inhibit P-gp, suggesting they are unlikely to cause drug-food dye interactions.

Keywords:
Drug transporterFood dyeP-glycoprotein

More Related Videos

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
14:57

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases

Published on: October 10, 2020

14.9K
Gap Junctional Intercellular Communication: A Functional Biomarker to Assess Adverse Effects of Toxicants and Toxins, and Health Benefits of Natural Products
05:27

Gap Junctional Intercellular Communication: A Functional Biomarker to Assess Adverse Effects of Toxicants and Toxins, and Health Benefits of Natural Products

Published on: December 25, 2016

15.4K

Related Experiment Videos

Last Updated: Dec 6, 2025

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria
06:38

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria

Published on: February 28, 2025

576
Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
14:57

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases

Published on: October 10, 2020

14.9K
Gap Junctional Intercellular Communication: A Functional Biomarker to Assess Adverse Effects of Toxicants and Toxins, and Health Benefits of Natural Products
05:27

Gap Junctional Intercellular Communication: A Functional Biomarker to Assess Adverse Effects of Toxicants and Toxins, and Health Benefits of Natural Products

Published on: December 25, 2016

15.4K

Area of Science:

  • Pharmacology
  • Biochemistry
  • Toxicology

Background:

  • P-glycoprotein (P-gp) is a crucial drug transporter involved in xenobiotic metabolism.
  • P-gp activity can be modulated by various substances, including food components, leading to potential drug interactions.
  • Arylsulfonate food dyes are widely consumed and their interaction with drug transporters warrants investigation.

Purpose of the Study:

  • To investigate the potential of six common arylsulfonate food dyes to modulate P-glycoprotein (P-gp) activity.
  • To determine if these food dyes act as activators or inhibitors of P-gp in vitro.
  • To assess the likelihood of clinical drug-food dye interactions mediated by P-gp.

Main Methods:

  • ATPase activity assays were used to evaluate P-gp activation by the food dyes in P-gp-expressing membranes.
  • Intracellular efflux assays in P-gp-expressing cells were performed to assess P-gp inhibition.
  • Verapamil and GF120918 were used as positive controls for P-gp activation and inhibition, respectively.

Main Results:

  • None of the six tested food dyes (allura red, carmoisine, ponceau 4R, quinolone yellow, sunset yellow, tartrazine) demonstrated stimulatory activity as P-gp activators.
  • The food dyes did not exhibit inhibitory activity against P-gp in the intracellular efflux assay.
  • In vitro studies showed no interaction between the tested food dyes and P-glycoprotein.

Conclusions:

  • The six common arylsulfonate food dyes investigated do not interact with P-glycoprotein in vitro.
  • These food dyes are unlikely to cause clinical drug-food dye interactions through P-gp modulation.
  • Further research is recommended to explore potential interactions of these food dyes with other drug transporters.